Role of the "other Babinski sign" in hyperkinetic facial disorders by Varanda, S et al.
Journal of the Neurological Sciences 378 (2017) 36–37
Contents lists available at ScienceDirect
Journal of the Neurological Sciences
j ourna l homepage: www.e lsev ie r .com/ locate / jnsClinical Short CommunicationRole of the “other Babinski sign” in hyperkinetic facial disorders☆Sara Varanda ⁎, Sofia Rocha, Margarida Rodrigues, Álvaro Machado, Gisela Carneiro
Neurology Department, Hospital de Braga, Sete Fontes, São Víctor, 4710-243 Braga, Portugal☆ This research did not receive any specific grant from
commercial, or not-for-profit sectors.
⁎ Corresponding author.
E-mail address: sara.varanda@hospitaldebraga.pt (S. V
http://dx.doi.org/10.1016/j.jns.2017.04.036
0022-510X/© 2017 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 27 November 2016
Received in revised form 12 April 2017
Accepted 21 April 2017
Available online 22 April 2017Background: The “other Babinski sign” consists in the co-contraction of the orbicularis and frontalismuscles, caus-
ing an eyebrow elevation during ipsilateral eye closure. It cannot be voluntarily reproduced.
Aims of the study: To determine the utility of this sign in the differential diagnosis of hyperkinetic facial disorders.
Methods: The presence of the sign was assessed in consecutive patients with blepharospasm, primary hemifacial
spasm or post-paralytic facial syndrome treated in a botulinum toxin outpatient clinic.
Results: Of the 99 patients identified, 86 were included, 41 with blepharospasm (32 female, mean age 71 ±
11 years), 28 with hemifacial spasm (16 female, mean age 65± 12 years) and 17 with post-paralytic facial syn-
drome (14 female, mean age 50 ± 17 years). The sign was detected in 67.9% of the patients with hemifacial
spasm, in 23.5% of the post-paralytic facial syndrome group and in none of the patients with blepharospasm,
exhibiting a sensitivity of 51% and a specificity of 100% for the diagnosis of hemifacial spasm/post-paralytic facial
syndrome and a specificity of 76% for hemifacial spasm, compared to post-paralytic facial syndrome.
Conclusions: This sign is highly specific for the diagnosis of peripherally induced hyperkinetic facial disorders. Its
assessment should integrate the routine examination of patients with abnormal facial movements.





The “other Babinski sign” consists in the co-contraction of the
orbicularis oculi and the internal part of frontalis muscles, leading to
eyebrow lifting during ipsilateral eye closure. Joseph Babinski noticed
this could not be voluntarily reproduced, thence its utility in
distinguishing organic facial disorders from functional conditions [1,2].
Blepharospasm, hemifacial spasm and reinnervation synkinesis are oc-
casionally difficult to distinguish. Blepharospasm is a focal facial dysto-
nia, of suspected multifactorial origin, consisting in involuntary,
spasmodic and synchronous contractions of orbicularis oculi muscles
in a spectrum from increased blinking to orbicular contraction interfer-
ingwith vision [3,4]. Hemifacial spasm consists in peripherally induced,
involuntary, irregular, clonic and/or tonic contractions ofmuscles inner-
vated by the ipsilateral facial nerve. Approximately 90% of the cases start
in the periorbital musculature, spreading later to adjacent muscles [5].
The most common aetiology is a compression of the facial nerve by a
vessel at its root exit zone. Post-paralytic facial syndrome results from
aberrant regeneration of the facial nerve after a paralysis, in a process
including axonal reinnervation errors and enhanced neuronal excitabil-
ity [6]. It comprises involuntary contraction of hemifacialmuscles, unin-
tended contractions triggered by voluntary movements (synkinesis)funding agencies in the public,
aranda).and myokymia [6]. More than 70% of the patients show simultaneous
involvement of upper and lower facial muscles from the outset [7].
Given the possible semiologic overlap of these disorders, we aimed
to prospectively determine the utility of the “other Babinski sign” in
their differential diagnosis.
2. Methods
The study was approved by the local ethics committee, written in-
formed consent was obtained from all participants and the principles
outlined in the Declaration of Helsinki were followed. The presence of
the sign was assessed in consecutive patients attending a botulinum
toxin outpatient clinic, diagnosed with blepharospasm, hemifacial
spasm or post-paralytic facial syndrome. Patients were evaluated
three to four months after the last treatment, in order to minimise con-
founding effects. Patients with other involuntary movements were ex-
cluded. In unclear cases, presence of the sign was evaluated by two
additional neurologists. Statistical analysis was performed using SPSS,
version 20 (IBM). Distribution normality was assessed through the Kol-
mogorov-Smirnov test. Fisher's test and chi-square were used to deter-
mine group differences, with an alpha set at 0.05 as the statistical
threshold for significance.
3. Results
Ninety-nine patients identified: 13 excluded, 10 because of concur-
rent movement disorders and three due to non-consensual assessment
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spasm (32 female, mean age 71 ± 11 years, range 48–96), 28 with
hemifacial spasm (16 female, mean age 65 ± 12 years, range 44–83,
61% left-sided, 39% right-sided) and 17 with post-paralytic facial
syndrome (14 female, mean age 50 ± 17 years, range 18–81, 65% left-
sided, 35% right-sided). All patients with hemifacial spasm had a MR
angiography. Neurovascular contact was detected in 13 (60.7%). The
“other Babinski sign” was present in 19 patients with hemifacial
spasm (67.9%), in four with post-paralytic facial syndrome (23.5%)
and in none of the blepharospasm group (Fig. 1). Analysing both the
patients with primary hemifacial spasm and post-paralytic facial
syndrome and taking the blepharospasm group as control, the sign
exhibited a sensitivity of 51% and a specificity of 100% for the diagnosis
of hemifacial spasm/post-paralytic facial syndrome. It was less frequent
in patients with past facial paralysis (p b 0.001). Accordingly, its
specificity for the diagnosis of hemifacial spasm was 76%, compared to
post-paralytic facial syndrome (32%). There was no difference
concerning detection of a vascular loop between patients with and
without the sign (p = 0.173).
4. Discussion
The “other Babinski sign”was frequent in primary hemifacial spasm,
less common in post-paralytic facial syndrome and absent in blepharo-
spasm, which confirms the results of previous studies [8–10]. The prev-
alence in hemifacial spasm found in our study was intermediate to
others published. Stamey and Jankovic detected the sign in 25.3% of
75 hemifacial spasm patients [8] and Pawlowski and colleagues deter-
mined a prevalence of 86% in 35 patients [9]. The first authors relied
on video records to assess the presence of the sign, while the latter
used direct observation. Although the search for the sign in a brief
video session probably renders an underestimation of its true preva-
lence [8], a recent study, using the same methodology, determined a
higher prevalence [10]. Some patients may reveal more subtle signs
(as those excluded because of non-consensual clinical evaluation).
Maybe a categorization of the patients in present, absent and possible
sign, would allow more comparable results. Our statistical measures of
the sign's performance did not differ significantly from the ones previ-
ously reported [8,9]. To our knowledge, this is the first study pointing
to a negative correlation between the “other Babinski sign” and past fa-
cial paralysis. Therefore, though present in almost a quarter of the pa-
tients with post-paralytic facial syndrome, this sign seems more
specific for the diagnosis of primary hemifacial spasm. It has been sug-
gested that the existence of different patterns of suprasegmental inner-
vation for the orbicularis oculi and frontalis muscles could explain theFig. 1. Typical patients with left-sided hemifacial spasm. The “other Babinski sign” is
evident as an elevation of the eyebrow caused by contraction of the frontalis muscle
during voluntary eye closure ipsilateral to the facial spasm.absence of this sign in blepharospasm [8]. Thus, the emergence of the
“other Babinski sign” in primary hemifacial spasm and in post-paralytic
facial syndrome, probably reflects the peripheral origin of these
disorders.
5. Limitations
The evaluation was non-blinded, but the inherent characteristics of
the syndromes largely preclude a blinded design. Patients undergoing
botulinum toxin treatmentmay be not fully representative of the gener-
al population with these abnormal movements. We assessed the sign
months after the last treatment, to ensure that it would not mask the
presence of the sign, although this cannot be fully warranted. The fact
that all patients were treated after the evaluation argues in favour of
minor impact of the last treatment. The post-paralytic facial syndrome
group may have been under-represented. We joined these patients
with the hemifacial spasm group to guarantee a reliable statistical anal-
ysis. Interrater reliability could be an interesting point to address, but it
was already demonstrated in another study [9].
6. Conclusions
The assessment of the “other Babinski sign” is a useful tool that
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